{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:40:47Z","timestamp":1767789647703,"version":"3.49.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing National Key Technology Research and Development Program of the Ministry of Science and Technology of China","award":["2013BAI09B03"],"award-info":[{"award-number":["2013BAI09B03"]}]},{"name":"Beijing National Key Technology Research and Development Program of the Ministry of Science and Technology of China","award":["2015BAI12B04"],"award-info":[{"award-number":["2015BAI12B04"]}]},{"name":"Beijing National Key Technology Research and Development Program of the Ministry of Science and Technology of China","award":["2014BAI04B01"],"award-info":[{"award-number":["2014BAI04B01"]}]},{"name":"Capital Characteristic Clinical Application Project","award":["Z181100001718196"],"award-info":[{"award-number":["Z181100001718196"]}]},{"name":"Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, China National Natural Science Foundation of China","award":["81930048"],"award-info":[{"award-number":["81930048"]}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special","doi-asserted-by":"publisher","award":["2022-2-2047"],"award-info":[{"award-number":["2022-2-2047"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital Health Development Research Project","award":["-2-2045"],"award-info":[{"award-number":["-2-2045"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502150"],"award-info":[{"award-number":["81502150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic subdural hematoma (CSDH) is a common neurosurgical condition that predominantly affects elderly individuals and is characterized by the accumulation of blood between the dura mater and the brain surface. Temporal muscle thickness (TMT) has emerged as a potential prognostic marker for various neurological diseases, including CSDH. This study aimed to evaluate the prognostic value of TMT in patients with CSDH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study assessed TMT in patients with CSDH using cranial CT scans. We examined the correlation between TMT and CSDH-related clinical characteristics and evaluated the prognostic relevance of TMT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 844 participants were included in the study. TMT was significantly lower in patients with CSDH than in the control group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). The difference in TMT was strongly associated with the side of CSDH occurrence (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), with CSDH more likely to develop on the side with lower TMT (OR\u2009=\u20090.219, 95% CI: 0.179\u20130.269). Lower average TMT was significantly associated with a higher likelihood of poor functional outcomes (OR\u2009=\u20090.560, 95% CI: 0.391\u20130.804,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). Additionally, our analysis showed significant associations between TMT and age (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), alcohol consumption (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), cardiac disease (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006), brain infarction (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), headache (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), limb weakness (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), and postoperative disturbance of consciousness (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The occurrence of CSDH is significantly correlated with the side of lower TMT. TMT may serve as an important prognostic marker in patients with CSDH, particularly for predicting functional outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1704557","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:13:36Z","timestamp":1767770016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of temporal muscle thickness in patients with chronic subdural hematoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Jingzhe","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoqi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingnan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunwei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/14656566.2020.1713095","article-title":"Drug treatment of chronic subdural hematoma","volume":"21","author":"Huang","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s41016-021-00263-z","article-title":"Evidence-based, expert consensus on drug treatment of chronic subdural hematoma","volume":"7","author":"Zhang","year":"2021","journal-title":"Chin Neurosurg J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/neurintsurg-2021-017352","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis","volume":"13","author":"Ironside","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s10143-023-02165-3","article-title":"Comparative outcomes of middle meningeal artery embolization with statins versus embolization alone in the treatment of chronic subdural hematoma: a systematic review and meta-analysis","volume":"46","author":"Musmar","year":"2023","journal-title":"Neurosurg Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"15910199231183132","DOI":"10.1177\/15910199231183132","article-title":"Liquid embolic agents for middle meningeal artery embolization in chronic subdural hematoma: institutional experience with systematic review and meta-analysis","author":"Sioutas","year":"2023","journal-title":"Interv Neuroradiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1097\/JS9.0000000000000699","article-title":"Comparative study on clinical outcomes and cost-effectiveness of chronic subdural hematomas treated by middle meningeal artery embolization and conventional treatment: a national cross-sectional study","volume":"109","author":"Tong","year":"2023","journal-title":"Int J Surg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnagi.2019.00325","article-title":"Effect of different factors on the short-term outcome of Chinese patients with primary chronic subdural hematoma at different age groups: a two-Center retrospective study","volume":"11","author":"Huang","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1206996","DOI":"10.3389\/fneur.2023.1206996","article-title":"Incidence, therapy, and outcome in the management of chronic subdural hematoma in Switzerland: a population-based multicenter cohort study","volume":"14","author":"El Rahal","year":"2023","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clineuro.2019.01.018","article-title":"A comparative study of chronic subdural hematoma in three age ranges: below 40 years, 41-79 years, and 80 years and older","volume":"178","author":"Ou","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"key":"ref10","first-page":"213","article-title":"Prognostic value of computerized rheoencephalography in chronic posttraumatic subdural hematoma: a preliminary report","volume":"39","author":"Krupa","year":"2005","journal-title":"Neurol Neurochir Pol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/diagnostics13142449","article-title":"Biofluid biomarkers in the prognosis of chronic subdural hematoma: a systematic scoping review","volume":"13","author":"Georgountzos","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/jcsm.13115","article-title":"Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand","volume":"14","author":"Zanker","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/gerona\/glab082","article-title":"Temporalis muscle thickness as an Indicator of sarcopenia is associated with long-term motor outcomes in Parkinson's disease","volume":"76","author":"Chung","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-019-05352-3","article-title":"Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review","volume":"177","author":"Aleixo","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.urolonc.2020.02.014","article-title":"Sarcopenia as a predictor of postoperative outcomes after urologic oncology surgery: a systematic review and meta-analysis","volume":"38","author":"Guo","year":"2020","journal-title":"Urol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.clnu.2019.10.021","article-title":"Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis","volume":"39","author":"Rinninella","year":"2020","journal-title":"Clin Nutr"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"17588359211008844","DOI":"10.1177\/17588359211008844","article-title":"Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis. Ther adv","volume":"13","author":"Surov","year":"2021","journal-title":"Med Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030687","article-title":"Temporal muscle and stroke-a narrative review on current meaning and clinical applications of temporal muscle thickness, area, and volume","volume":"14","author":"Katsuki","year":"2022","journal-title":"Nutrients"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-018-2948-8","article-title":"Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases","volume":"140","author":"Furtner","year":"2018","journal-title":"J Neuro-Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1007\/s00330-020-07471-8","article-title":"Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis","volume":"31","author":"Muglia","year":"2020","journal-title":"Eur Radiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1158\/1078-0432.CCR-21-1987","article-title":"Temporal muscle thickness as a prognostic marker in patients with newly diagnosed glioblastoma: translational imaging analysis of the CENTRIC EORTC 26071-22072 and CORE trials","volume":"28","author":"Furtner","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3171\/2021.12.JNS212193","article-title":"Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer","author":"Cho","year":"2022","journal-title":"J Neurosurg"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/cancers13030566","article-title":"Evaluation of the temporal muscle thickness as an independent prognostic biomarker in patients with primary central nervous system lymphoma","volume":"13","author":"Furtner","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.3390\/jcm11216456","article-title":"Significance of temporal muscle thickness in chronic subdural hematoma","volume":"11","author":"Dubinski","year":"2022","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/jgs.18664","article-title":"Association between sarcopenia and risk of major adverse cardiac and cerebrovascular events-UK biobank database","volume":"72","author":"Jauffret","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and cardiovascular diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jcsm.13221","article-title":"Sarcopenia and cardiovascular diseases: a systematic review and meta-analysis","volume":"14","author":"Zuo","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/jcm9051272","article-title":"Sarcopenia in neurological patients: standard values for temporal muscle thickness and muscle strength evaluation","volume":"9","author":"Steindl","year":"2020","journal-title":"J Clin Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/JPD-225108","article-title":"Temporal muscle thickness correlates with sarcopenia in Parkinson's disease","volume":"13","author":"Peball","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/nu14235048","article-title":"Predictive value of temporal muscle thickness for sarcopenia after acute stroke in older patients","volume":"14","author":"Nagano","year":"2022","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.25259\/SNI_814_2020","article-title":"Temporal muscle thickness and area are an independent prognostic factors in patients aged 75 or younger with aneurysmal subarachnoid hemorrhage treated by clipping","volume":"12","author":"Katsuki","year":"2021","journal-title":"Surg Neurol Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1227\/neu.0000000000003013","article-title":"Relative cortical atrophy index as a strong predictor of recurrence after surgery for chronic subdural hematoma","volume":"95","author":"Charehsaz","year":"2024","journal-title":"Neurosurgery"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00701-002-0994-6","article-title":"Chronic subdural haematoma and the enigmatic eosinophil","volume":"144","author":"Sarkar","year":"2002","journal-title":"Acta Neurochir"},{"key":"ref37","first-page":"211","article-title":"Morphological aspects of the traumatic chronic subdural hematoma capsule: SEM studies","volume-title":"Microsc Microanal","author":"Moskala","year":"2007"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","article-title":"Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy","volume":"14","author":"Edlmann","year":"2017","journal-title":"J Neuroinflammation"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3357\/ASEM.3331.2012","article-title":"High altitude induced bilateral non-traumatic subdural hematoma","volume":"83","author":"Ganau","year":"2012","journal-title":"Aviat Space Environ Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1704557\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:13:38Z","timestamp":1767770018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1704557\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":39,"alternative-id":["10.3389\/fneur.2025.1704557"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1704557","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1704557"}}